In free fall, Clovis defaults on loan and agrees to further restrict Rubraca use — With Neogene buy and a CAR-T in the clinic, AstraZeneca builds up cell therapy 'library' — With new data, Nkarta builds case for ‘natural killer’ cell therapy -- See more on our front page news http://bit.ly/w28kSd #clovisoncology #rubraca #ovariancancer #loandefault #celltherapy #astrazeneca #naturalkillercells #biotech #biotechnology #biopharma #pharma #pharmanews #cafepharma
#clovisoncology #rubraca #ovariancancer #loandefault #CellTherapy #astrazeneca #naturalkillercells #biotech #biotechnology #biopharma #pharma #pharmanews #cafepharma